Literature DB >> 2654292

Reactivity of the human monoclonal antibody 33G2 with repeated sequences of three distinct Plasmodium falciparum antigens.

R Udomsangpetch1, J Carlsson, B Wåhlin, G Holmquist, L S Ozaki, A Scherf, D Mattei, O Mercereau-Puijalon, S Uni, M Aikawa.   

Abstract

The human mAb 33G2 has high capacity to inhibit in vitro invasion of erythrocytes by Plasmodium falciparum merozoites and, thus, is of special interest with regard to protective immunity against the parasite. In order to obtain more information about asexual blood stage Ag of P. falciparum that are seen by this antibody, material from synchronized P. falciparum cultures was studied by immunofluorescence, immunoelectron microscopy, and immunoblotting. Reactivity was mainly confined to the membrane of infected erythrocytes. Soon after merozoite invasion the antibody stained the erythrocyte membrane. This membrane-associated staining faded during intracellular development of the parasites. Beginning about 18 h after invasion, a dotted pattern appeared which increased in strength with time and persisted to schizont rupture. Pf155/RESA was the major Ag recognized in immunoblots of parasites collected throughout the entire erythrocytic cycle, although other polypeptides also bound the antibody. Among these was a 260-kDa polypeptide found in late trophozoites and schizonts. The specificity of the antibody was analyzed with synthetic peptides corresponding to repeated sequences in the P. falciparum Ag Pf155/RESA, Pf11.1, and Ag332. Synthetic peptides related to Ag332 were the most efficient inhibitors of antibody binding in immunofluorescence studies and cell ELISA. A beta-galactosidase-Ag332 fusion protein was also efficient in reversing reinvasion inhibition caused by 33G2. These results define a family of cross-reactive P. falciparum Ag recognized by mAb 33G2 and suggest that Ag332 was its original target.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2654292

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Structure and possible function of Plasmodium falciparum proteins exported to the erythrocyte membrane.

Authors:  B Knapp; E Hundt; K R Lingelbach
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

2.  Immune responses in congenic mice to multiple antigen peptides based on defined epitopes from the malaria antigen Pf332.

Authors:  N Ahlborg; R Andersson; P Perlmann; K Berzins
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

3.  Passive immunization of Aotus monkeys with human antibodies to the Plasmodium falciparum antigen Pf155/RESA.

Authors:  K Berzins; H Perlmann; B Wåhlin; H P Ekre; B Högh; E Petersen; B Wellde; M Schoenbechler; J Williams; J Chulay
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

4.  Immunogenicity and antigenicity in rabbits of a repeated sequence of Plasmodium falciparum antigen Pf155/RESA fused to two immunoglobulin G-binding domains of staphylococcal protein A.

Authors:  A Sjölander; S Ståhl; P A Nygren; L Aslund; N Ahlborg; B Wåhlin; A Scherf; K Berzins; M Uhlén; P Perlmann
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

6.  Seroreactivity with the Plasmodium falciparum blood stage antigen Pf332 in adults and children from malaria-endemic regions.

Authors:  J Iqbal; P Perlmann; B M Greenwood; K Berzins
Journal:  Clin Exp Immunol       Date:  1993-10       Impact factor: 4.330

7.  Involvement of Pf155/RESA and cross-reactive antigens in Plasmodium falciparum merozoite invasion in vitro.

Authors:  B Wåhlin; A Sjölander; N Ahlborg; R Udomsangpetch; A Scherf; D Mattei; K Berzins; P Perlmann
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

8.  Functional alteration of red blood cells by a megadalton protein of Plasmodium falciparum.

Authors:  Fiona K Glenister; Kate M Fernandez; Lev M Kats; Eric Hanssen; Narla Mohandas; Ross L Coppel; Brian M Cooke
Journal:  Blood       Date:  2008-10-02       Impact factor: 22.113

9.  Characterization of the Duffy-Binding-Like Domain of Plasmodium falciparum Blood-Stage Antigen 332.

Authors:  Sandra Nilsson; Kirsten Moll; Davide Angeletti; Letusa Albrecht; Inari Kursula; Ning Jiang; Xiaodong Sun; Klavs Berzins; Mats Wahlgren; Qijun Chen
Journal:  Malar Res Treat       Date:  2011-09-19

10.  A novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion.

Authors:  Kirsten Moll; Arnaud Chêne; Ulf Ribacke; Osamu Kaneko; Sandra Nilsson; Gerhard Winter; Malin Haeggström; Weiqing Pan; Klavs Berzins; Mats Wahlgren; Qijun Chen
Journal:  PLoS One       Date:  2007-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.